Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 14, 2026
América Móvil (AMX) Prepares to Report Second-Quarter 2026 Results

América Móvil (AMX) Prepares to Report Second-Quarter 2026 Results

Key Takeaways

  • América Móvil is scheduled to report second-quarter 2026 financial and operating results after market close on July 21, with a conference call the following day.
  • Analysts are focused on revenue trends in the company's core wireless and fixed-line segments across Latin America.
  • Consensus expectations center on modest earnings per share growth compared to the prior year period.
  • Investors will monitor subscriber additions, average revenue per user trends, and any updates on capital spending plans.
  • Broader industry conditions, including competition and currency fluctuations in key markets, remain important themes.
  • Historical stock reactions to earnings have varied based on how results align with guidance and peer performance.

Why This Earnings Report Matters

América Móvil stands as the largest telecommunications provider in Latin America, serving hundreds of millions of wireless subscribers across multiple countries. Its quarterly results provide valuable insight into regional consumer spending patterns, digital adoption rates, and competitive dynamics within the telecom sector. After a solid first quarter of 2026, the upcoming second-quarter release will help clarify whether that momentum is holding up amid shifting economic conditions in markets such as Mexico and Brazil. The numbers also shape views on the company’s capacity to maintain dividends and support ongoing network investments.

What Analysts Expect

Current consensus points to second-quarter 2026 earnings per share of approximately $0.46 for América Móvil, reflecting ongoing attention to operational efficiency. Revenue is projected to post year-over-year growth, supported mainly by increases in wireless services, although exact figures differ slightly across data providers. Attention will center on any updates to full-year subscriber targets and margin guidance. In the previous quarter, results showed a mixed pattern of beats and misses relative to estimates, with revenue frequently coming in ahead of forecasts. The stock has shown varied volatility around these announcements, with the magnitude of moves often tied to how reported metrics compare with expectations and peer telecom performance. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Market Sentiment Heading Into the Report

Sentiment ahead of the release looks cautiously optimistic, underpinned by the company’s scale and its recurring-revenue profile. Key risks include potential softness in emerging markets, foreign-exchange volatility, and any indication of slower subscriber growth. Options activity has picked up as investors position for the announcement, which is typical in the pre-earnings window. A stronger-than-expected outcome could support share-price gains, whereas shortfalls in important metrics might trigger near-term pressure.

Using AI Tools to Refine the View

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. AI Screener

Key Factors to Monitor After the Release

Once the results are out, focus will shift to management commentary on demand trends and cost discipline. Updates on network modernization spending will be important for assessing long-term competitiveness. Currency movements in Latin American markets often influence reported figures and are likely to feature in the discussion. Demand signals from both enterprise and residential segments can offer clues about broader economic conditions in the region.

Any revisions to guidance will help shape expectations for the second half of the year. Margin pressures stemming from inflation or competition may also be addressed. Industry dynamics, including 5G rollout progress and regulatory developments, remain relevant when evaluating sustainable growth. Keeping an eye on these elements provides useful context for the company’s trajectory beyond the immediate quarter.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AMX

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


AMX's RSI Indicator is remaining in oversold zone for 2 days

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMX advanced for three days, in of 324 cases, the price rose further within the following month. The odds of a continued upward trend are .

AMX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMX as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AMX turned negative on July 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

AMX moved below its 50-day moving average on July 27, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AMX crossed bearishly below the 50-day moving average on July 31, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.803) is normal, around the industry mean (10.315). P/E Ratio (13.785) is within average values for comparable stocks, (30.738). Projected Growth (PEG Ratio) (0.901) is also within normal values, averaging (10.324). Dividend Yield (0.025) settles around the average of (0.043) among similar stocks. P/S Ratio (1.289) is also within normal values, averaging (7.171).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AMX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Verizon Communications (NYSE:VZ), AT&T (NYSE:T), Comcast Corp (NASDAQ:CMCSA), Lumen Technologies (NYSE:LUMN).

Industry description

Major telecommunications include companies that make communication possible across the globe – by providing voice and data transmission via multiple channels such as phone or the Internet, through airwaves or cables, through wires or wirelessly. The ease with which we connect with anyone, anywhere in the world is thanks in large part to the infrastructure created by the telecom industry. Some major telecom players include AT&T Inc., Verizon Communications Inc. and Nippon Telegraph and Telephone Corporation.

Market Cap

The average market capitalization across the Major Telecommunications Industry is 17.77B. The market cap for tickers in the group ranges from 714.84K to 217.48B. SFTBY holds the highest valuation in this group at 217.48B. The lowest valued company is CPROF at 714.84K.

High and low price notable news

The average weekly price growth across all stocks in the Major Telecommunications Industry was 3%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was -0%. PCLA experienced the highest price growth at 65%, while CCOI experienced the biggest fall at -27%.

Volume

The average weekly volume growth across all stocks in the Major Telecommunications Industry was -27%. For the same stocks of the Industry, the average monthly volume growth was -24% and the average quarterly volume growth was -34%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 69
Price Growth Rating: 58
SMR Rating: 75
Profit Risk Rating: 84
Seasonality Score: -19 (-100 ... +100)
View a ticker or compare two or three
AMX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of wireless telecommunications services

Industry MajorTelecommunications

Profile
Details
Industry
Wireless Telecommunications
Address
Lago Zurich 245, Plaza Carso / Edificio Telcel
Phone
+52 5525813700
Employees
176014
Web
https://www.americamovil.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.